Subsense is a pioneering company dedicated to developing non-surgical, nanoparticle-based brain-computer interfaces (BCIs) aimed at enhancing human potential and transforming healthcare. Their mission is to create safe, effective, and accessible BCIs that redefine the interaction between human cognition and technology. 

The company's innovative approach utilizes biocompatible nanoparticles engineered to seamlessly integrate with the brain, enabling accurate recording and stimulation of neural activity without the need for surgical implants. This non-invasive technology is designed to assist individuals with paralysis and neurological disorders by translating thoughts into digital commands, thereby restoring motor functions and offering new levels of independence.